Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Altace, Apo-Ramipril, Sandoz-Ramipril (Show all)
Ramipril is an angiotensin-converting enzyme (ACE) inhibitor that is used alone or in combination with diuretics for hypertension and to reduce risk of heart attack an stroke in high risk patients. Off label it is used for heart failure and to reduce heart problems in diabetics with hypertension.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Elevated blood pressure | 33 | 12 |
|
|
|
|
|
| Hypertension | 29 | 4 |
|
|
|
||
| Other | 17 | 4 |
|
|
|||
| Ace Inhibitor to protect heart and kidneys. | 4 | 1 |
|
||||
| CHF (Congestive heart failure) | 3 | 0 | |||||
| Increase effect of another treatment | 2 | 0 |
See all 92 patients currently taking Ramipril
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Ramipril
| Dry cough | 3 | |
|---|---|---|
| Sedation | 2 | |
| Sore throat (Pharyngitis) | 1 | |
| Headaches in right eye and neck | 1 | |
| Sleepiness | 1 | |
| Drowsiness | 1 | |
| See all 17 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Ramipril. See all 11 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Doctor's advice | 13 | ||
| Side effects too severe | 9 | ||
| Did not seem to work | 1 | ||
| Other | 1 |
Adherence
Taking treatment as prescribed
Adherence of Ramipril
Always |
18 | 78% |
|
|---|---|---|---|
Usually |
3 | 13% |
|
Sometimes |
0 | 0% |
|
Never |
2 | 9% |
|
Burden
Difficulty being on treatment
Burden of Ramipril
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
2 | 9% |
|
A little |
2 | 9% |
|
Not at all |
19 | 83% |
|
Cost
Paid out of pocket
Cost of Ramipril
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
2 | 13% |
|
$25-49 |
0 | 0% |
|
< $25 |
14 | 88% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 11, 2012.